蒙草生態(300355.SZ):聯合體中標14.61億元鄉土樹種混交林建設工程
格隆匯9月14日丨蒙草生態(300355.SZ)公佈,公司近日收到代理機構中化建國際招標有限責任公司發來的《中標通知書》,公司、中國地質礦業有限公司、北礦城生態科技集團有限公司為歐洲投資銀行貸款內蒙古通遼市科爾沁沙地綜合治理項目鄉土樹種混交林建設工程2包的聯合中標人,中標合同金額相當於約1.92億歐元(以投標時歐元兑人民幣匯率7.60,約合人民幣14.61億元)。
公司作為聯合體的牽頭人將負責該項目60%暨約合人民幣8.77億元的建設施工。若公司後續能簽訂正式項目合同並順利實施,將對公司未來經營業績產生積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.